Skip to main content

NewcelX Ltd.

NCEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001783036

No open-market purchases or sales by NewcelX Ltd. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $42.6K in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, 0 vs. previous quarter
4
13F valueReported value at the end of Q2 2026
$42.6K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding NCEL, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding NCEL at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by NewcelX Ltd. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 29, 2026 (view filing)Apr 272 daysSamuel OlivierDirectorPPurchaseCommon Shares, par value CHF 0.05 per share+81.8K$2.75+$225.0KNew position81.8K after
Apr 29, 2026 (view filing)Apr 272 daysSamuel OlivierDirectorPPurchaseCommon Shares, par value CHF 0.05 per share+114.5K–––114.5K afterDerivative
Apr 29, 2026 (view filing)Apr 272 daysRevel MichelCSO and DirectorPPurchaseCommon Shares, par value CHF 0.05 per share+54.5K$2.75+$150.0K+6.0%957.5K after
Apr 29, 2026 (view filing)Apr 272 daysRevel MichelCSO and DirectorPPurchaseCommon Shares, par value CHF 0.05 per share+76.4K–––76.4K afterDerivative

Top 10 13F holders, Q2 2026

The largest institutional positions in NewcelX Ltd. at the end of Q2 2026; share changes are against Q1 2026.

See all 4 holders
Institutions holding NCEL in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
HRT Financial LP11,199$40.0K0.00%+11,199New
Jones Financial Companies LLLP700$2.55K0.00%+700New
Caitong International Asset Management Co., Ltd9$330.00%+8+800.0%Added
CoreCap Advisors, LLC3$110.00%00.0%Unchanged